Edition:
United States

Merus NV (MRUS.OQ)

MRUS.OQ on NASDAQ Stock Exchange Global Market

19.20USD
25 Sep 2018
Change (% chg)

-- (--)
Prev Close
$19.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
14,273
52-wk High
$26.49
52-wk Low
$14.24

Chart for

About

Merus NV is a biotechnology company based in the Netherlands. The Company develops differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Biclonics format. Its products include, among others, MCLA-134 that is designed to bind to a combination of two immunomodulatory targets... (more)

Overall

Beta: --
Market Cap(Mil.): $435.31
Shares Outstanding(Mil.): 22.62
Dividend: --
Yield (%): --

Financials

  MRUS.OQ Industry Sector
P/E (TTM): -- 109.17 32.55
EPS (TTM): -2.50 -- --
ROI: -21.23 1.47 12.80
ROE: -51.90 0.22 14.92

BRIEF-Merus Files Prospectus Relates To Proposed Resale Or Other Disposition Of Co's Shares By Selling Shareholders

* MERUS NV FILES PROSPECTUS RELATES TO PROPOSED RESALE OR OTHER DISPOSITION OF UP TO 3.1 MILLION OF CO'S COMMON SHARES BY SELLING SHAREHOLDERS - SEC FILING Source http://bit.ly/2jXQqy0 Further company coverage:

May 15 2018

BRIEF-Merus Q4 Loss Per Share EUR 0.73

* MERUS ANNOUNCES RECENT CORPORATE DEVELOPMENTS AND FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2017

Apr 26 2018

Earnings vs. Estimates